Gene · 3984
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ancestry- and sex-specific effects underlying inguinal hernia susceptibility identified in a multiethnic genome-wide association study meta-analysis. | Hum Mol Genet | 2022 | 35022708 | PubTator, text mining | PubMed |
| RHOA inhibits chondrogenic differentiation of mesenchymal stem cells in adolescent idiopathic scoliosis. | Connect Tissue Res | 2022 | 35019797 | PubTator, text mining | PubMed |
| A Protein Composite Neural Scaffold Modulates Astrocyte Migration and Transcriptome Profile. | Macromol Biosci | 2022 | 35014754 | PubTator, text mining | PubMed |
| NETME: on-the-fly knowledge network construction from biomedical literature. | Appl Netw Sci | 2022 | 35013714 | PubTator, text mining | PubMed |
| Long non-coding RNA nuclear-enriched abundant transcript 1 (LncRNA NEAT1) upregulates Cyclin T2 (CCNT2) in laryngeal papilloma through sponging miR-577/miR-1224-5p and blocking cell apoptosis. | Bioengineered | 2022 | 35012431 | PubTator, text mining | PubMed |
| Structural Aspects of LIMK Regulation and Pharmacology. | Cells | 2022 | 35011704 | PubTator, text mining | PubMed |
| Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. | J Cell Mol Med | 2022 | 34907642 | PubTator, text mining | PubMed |
| Polypharmacologic Reprogramming of Tumor-Associated Macrophages toward an Inflammatory Phenotype. | Cancer Res | 2022 | 34903600 | PubTator, text mining | PubMed |
| 25-hydroxycholesterol-induced cell death via activation of ROCK/LIMK/cofilin axis in colorectal cancer cell spheroids. | J Steroid Biochem Mol Biol | 2022 | 34861388 | PubTator, text mining | PubMed |
| BAIAP2L1 enables cancer cell migration and facilitates phospho-Cofilin asymmetry localization in the border cells. | Cancer Commun (Lond) | 2022 | 34811939 | PubTator, text mining | PubMed |
| Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how. | Biol Rev Camb Philos Soc | 2022 | 34811887 | PubTator, text mining | PubMed |
| Small Molecules as LIM Kinase Inhibitors. | Curr Med Chem | 2022 | 34702151 | PubTator, text mining | PubMed |
| The potential role of cofilin-1 in promoting triple negative breast cancer (TNBC) metastasis via the extracellular vesicles (EVs). | Transl Oncol | 2022 | 34678587 | PubTator, text mining | PubMed |
| Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer. | Mol Carcinog | 2022 | 34559922 | PubTator, text mining | PubMed |
| miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis. | Gastroenterology | 2022 | 34547282 | PubTator, text mining | PubMed |
| Drug-resistant epilepsy: Drug target hypothesis and beyond the receptors. | Epilepsia Open | 2022 | 34542940 | PubTator, text mining | PubMed |
| Neuroligin-3 and neuroligin-4X form nanoscopic clusters and regulate growth cone organization and size. | Hum Mol Genet | 2022 | 34542148 | PubTator, text mining | PubMed |
| The Genetic Basis of Moyamoya Disease. | Transl Stroke Res | 2022 | 34529262 | PubTator, text mining | PubMed |
| Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis. | Acta Pharmacol Sin | 2022 | 34294886 | PubTator, text mining | PubMed |
| Genetic causes of neonatal and infantile hypercalcaemia. | Pediatr Nephrol | 2022 | 33990852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3984/papers?page=30